Literature DB >> 30317418

IgE Test in Secretions of Patients with Respiratory Allergy.

Carmen Rondón1, Ibon Eguíluz-Gracia1, Mohamed H Shamji2, Janice A Layhadi2, María Salas1, María José Torres1, Paloma Campo3,4.   

Abstract

PURPOSE OF REVIEW: IgE is a key player in multiple inflammatory airway diseases. Ample literature demonstrates its presence in mucosa of patients with allergic rhinitis (AR), local allergic rhinitis (LAR), asthma, or chronic rhinosinusitis with nasal polyposis (CRSwNP). RECENT
FINDINGS: Current evidence shows that high-affinity IgE in blood stream of allergic individuals derives mainly from the mucosae. Also, mucosal synthesis of IgE can occur in the absence of systemic atopy, and may be relevant in atopic and non-atopic phenotypes of rhinitis as demonstrated in LAR. Specific IgE (sIgE) detection varies depending on technique used for sample collection and its measurement. sIgE detection is highly specific for diagnosis of LAR. Moreover, measurement of sIgE in secretions could be useful in monitoring response to allergen-specific immunotherapy in both AR and LAR phenotypes. This review will focus on recent developments in the role of IgE in respiratory diseases, and the clinical implications of its measurement in secretions.

Entities:  

Keywords:  Allergen-specific immunotherapy; Allergic; IgE; Local allergic rhinitis; Rhinitis

Mesh:

Substances:

Year:  2018        PMID: 30317418     DOI: 10.1007/s11882-018-0821-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  92 in total

Review 1.  Local IgE production in the nasal mucosa: a review.

Authors:  W J Fokkens; J G Vinke; A KleinJan
Journal:  Am J Rhinol       Date:  2000 Sep-Oct

Review 2.  Local allergic rhinitis: concept, pathophysiology, and management.

Authors:  Carmen Rondón; Paloma Campo; Alkis Togias; Wytske J Fokkens; Stephen R Durham; Desmond G Powe; Joaquim Mullol; Miguel Blanca
Journal:  J Allergy Clin Immunol       Date:  2012-04-18       Impact factor: 10.793

3.  A quantitative analysis of cedar pollen-specific immunoglobulins in nasal lavage supported the local production of specific IgE, not of specific IgG.

Authors:  Tomoaki Yoshida; Ayako Usui; Taeko Kusumi; Shigeru Inafuku; Tsuyoshi Sugiyama; Naoki Koide; Takashi Yokochi
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

4.  Role of the basophil activation test in the diagnosis of local allergic rhinitis.

Authors:  Enrique Gómez; Paloma Campo; Carmen Rondón; Esther Barrionuevo; Natalia Blanca-López; María José Torres; Rocío Herrera; Luisa Galindo; Cristobalina Mayorga; Miguel Blanca
Journal:  J Allergy Clin Immunol       Date:  2013-08-31       Impact factor: 10.793

5.  Measurement of Japanese cedar pollen-specific IgE in nasal secretions.

Authors:  Hiroshi Sakaida; Sawako Masuda; Kazuhiko Takeuchi
Journal:  Allergol Int       Date:  2014-09       Impact factor: 5.836

6.  Distribution of gamma E-forming cells in lymphoid tissues of the human and monkey.

Authors:  T Tada; K Ishizaka
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

7.  Identification of allergic disease among users of antihistamines.

Authors:  Sheryl L Szeinbach; Brock Williams; Pieter Muntendam; Richard D O'Connor
Journal:  J Manag Care Pharm       Date:  2004 May-Jun

8.  Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests.

Authors:  K G Huggins; J Brostoff
Journal:  Lancet       Date:  1975-07-26       Impact factor: 79.321

9.  Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.

Authors:  Carmen Rondón; Javier Fernández; Soledad López; Paloma Campo; Inmaculada Doña; Maria J Torres; Cristobalina Mayorga; Miguel Blanca
Journal:  J Allergy Clin Immunol       Date:  2009-10-01       Impact factor: 10.793

10.  Sequential class switching is required for the generation of high affinity IgE antibodies.

Authors:  Huizhong Xiong; Jayashree Dolpady; Matthias Wabl; Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  J Exp Med       Date:  2012-01-16       Impact factor: 14.307

View more
  6 in total

1.  Nasal specific IgE to Der p is not an acceptable screening test to predict the outcome of the nasal challenge test in patients with non-allergic rhinitis.

Authors:  Luis Santamaría; Ana Calle; Manuela Tejada-Giraldo Biol; Victor Calvo; Jorge Sánchez; Ricardo Cardona
Journal:  World Allergy Organ J       Date:  2020-09-28       Impact factor: 4.084

Review 2.  Precision Medicine in House Dust Mite-Driven Allergic Asthma.

Authors:  Ibon Eguiluz-Gracia; Francisca Palomares; Maria Salas; Almudena Testera-Montes; Adriana Ariza; Ignacio Davila; Joan Bartra; Cristobalina Mayorga; Maria Jose Torres; Carmen Rondon
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

Review 3.  Diagnostic Tools in Allergic Rhinitis.

Authors:  Almudena Testera-Montes; Raquel Jurado; Maria Salas; Ibon Eguiluz-Gracia; Cristobalina Mayorga
Journal:  Front Allergy       Date:  2021-09-23

Review 4.  Role of microRNAs in type 2 diseases and allergen-specific immunotherapy.

Authors:  Constanze A Jakwerth; Hannah Kitzberger; Dimitrii Pogorelov; Annika Müller; Simon Blank; Carsten B Schmidt-Weber; Ulrich M Zissler
Journal:  Front Allergy       Date:  2022-09-12

Review 5.  Local Respiratory Allergy: From Rhinitis Phenotype to Disease Spectrum.

Authors:  Almudena Testera-Montes; Maria Salas; Francisca Palomares; Adriana Ariza; María J Torres; Carmen Rondón; Ibon Eguiluz-Gracia
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

6.  Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvant.

Authors:  Cathy Leonard; Guillem Montamat; Caroline Davril; Olivia Domingues; Oliver Hunewald; Dominique Revets; Coralie Guerin; Simon Blank; Justine Heckendorn; Gauthier Jardon; François Hentges; Markus Ollert
Journal:  Allergy       Date:  2021-01-05       Impact factor: 13.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.